BBL
IBB icon

Beck Bode LLC’s iShares Biotechnology ETF IBB Stock Holding History

Beck Bode LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
1,350
+46
+4% +$7.91K 0.04% 92
2026
Q1 		$220K Sell
1,304
-464
-26% -$79.3K 0.04% 87
2025
Q4 		$298K Sell
1,768
-237
-12% -$38.5K 0.05% 83
2025
Q3 		$289K Sell
2,005
-398
-17% -$54.3K 0.05% 83
2025
Q2 		$304K Sell
2,403
-1,216
-34% -$149K 0.05% 88
2025
Q1 		$463K Sell
3,619
-787
-18% -$107K 0.09% 80
2024
Q4 		$583K Sell
4,406
-1,900
-30% -$267K 0.11% 87
2024
Q3 		$918K Sell
6,306
-2,640
-30% -$382K 0.17% 74
2024
Q2 		$1.23M Sell
8,946
-2,506
-22% -$335K 0.25% 67
2024
Q1 		$1.57M Sell
11,452
-1,728
-13% -$236K 0.32% 71
2023
Q4 		$1.79M Sell
13,180
-230
-2% -$28.1K 0.4% 70
2023
Q3 		$1.64M Sell
13,410
-552
-4% -$70.2K 0.42% 69
2023
Q2 		$1.77M Sell
13,962
-703
-5% -$91.3K 0.43% 67
2023
Q1 		$1.89M Sell
14,665
-1,290
-8% -$169K 0.47% 66
2022
Q4 		$2.09M Sell
15,955
-190
-1% -$24.6K 0.47% 63
2022
Q3 		$1.89M Buy
+16,145
New +$2M 0.41% 68

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Beck Bode LLC's IBB Position: Q2 2026 in Review

Beck Bode LLC increased its iShares Biotechnology ETF (IBB) stake by 3.5% in Q2 2026, buying an estimated $7.91K and bringing the position to 1,350 shares worth $257K. The position accounts for 0.04% of the portfolio, ranked #92.

Beck Bode LLC first reported a position in IBB in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.09M in Q4 2022. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Beck Bode LLC held 1,350 shares of iShares Biotechnology ETF worth $257K as of Q2 2026.
  • Beck Bode LLC bought 46 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.91K.
  • iShares Biotechnology ETF made up 0.04% of Beck Bode LLC's portfolio in Q2 2026, its #92 holding.
  • Beck Bode LLC first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 16 quarters since.
  • Beck Bode LLC's iShares Biotechnology ETF position peaked at $2.09M in Q4 2022.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.